Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $0.05
15% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $211.0K | $33.2M | −$41.5M | −$5.1M | −$16.3M | −$9.0K | $260.0K | $83.0K |
| Cost of revenue | $724.0K | $7.0K | $10.0K | $1.0K | $6.0K | $0 | $0 | $0 |
| Gross profit | −$513.0K | $33.2M | −$41.6M | −$71.0K | −$16.3M | −$9.0K | $260.0K | $83.0K |
| Gross margin | -243.1% | 100.0% | 100.0% | 1.4% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $232.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $33.7M | −$2.7M | −$1.6M | −$1.6M | −$17.8M | −$1.6M | −$844.0K | −$808.0K |
| EBITDA | −$23.7M | −$2.7M | −$42.9M | −$6.8M | −$17.8M | −$1.6M | −$844.0K | −$808.0K |
| Net income | $29.0M | $21.6M | −$40.1M | −$4.0M | −$15.9M | −$4.0M | −$131.0K | $243.0K |
| Net margin | 13746.9% | 65.1% | 96.5% | 78.7% | 97.5% | 44266.7% | -50.4% | 292.8% |
| EPS (diluted) | 0.13 | 0.09 | -0.18 | -0.02 | -0.07 | -0.02 | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
UNDERWOOD CAP LTD
No one on the platform currently holds MMJJF.
No tracked institution reports a position in MMJJF as of their last filing.
No one on the platform has traded MMJJF yet.
| $16M |
| — |
| MDBIFTrivarX Limited | $0.00 | +0.00% | $2M | — |
| NYMXFNymox Pharmaceutical Corporation | $0.12 | +0.00% | $11M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.